GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dannex Ayrton Starwin PLC (XGHA:DASPHARMA) » Definitions » Change In Working Capital

Dannex Ayrton Starwin (XGHA:DASPHARMA) Change In Working Capital : GHS0.00 Mil (TTM As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Dannex Ayrton Starwin Change In Working Capital?

Dannex Ayrton Starwin's change in working capital for the quarter that ended in . 20 was GHS0.00 Mil.

Dannex Ayrton Starwin's change in working capital for the fiscal year that ended in . 20 was GHS0.00 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).


Dannex Ayrton Starwin Change In Working Capital Historical Data

The historical data trend for Dannex Ayrton Starwin's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dannex Ayrton Starwin Change In Working Capital Chart

Dannex Ayrton Starwin Annual Data
Trend
Change In Working Capital

Dannex Ayrton Starwin Semi-Annual Data
Change In Working Capital

Dannex Ayrton Starwin Change In Working Capital Calculation

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Working Capital for the trailing twelve months (TTM) ended in . 20 was GHS0.00 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows Fiscal Years EndedJanuary 31,(Amounts in millions)
Cash flows from operating activities: 2014 2013 2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net (566) (614) (796)
Inventories (1,667) (2,759) (3,727)
Accounts payable 531 1,061 2,687
Accrued liabilities 103 271 (935)
Accrued income taxes (1,224) 981 994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dannex Ayrton Starwin Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Dannex Ayrton Starwin's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Dannex Ayrton Starwin (XGHA:DASPHARMA) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 5 Dadeban Road, Ring Road North, North Industrial Area, Accra, GHA
Dannex Ayrton Starwin PLC is a pharmaceutical company. The company offers a product range that includes tablets, capsules, liquids syrups and suspensions, powders, ointments, and chemicals. It also manufactures and distributes Vitamin C.

Dannex Ayrton Starwin (XGHA:DASPHARMA) Headlines

No Headlines